- Certain Birth Control Pills May Increase Cancer Risk
- Writing May Help Cancer Survivors
- New Method May Allow Breast Cancer Drug to Be Given Through Skin
- Findings Raise Hope of Preventing Breast Cancer with Statins
- Avoiding a Second Biopsy for Breast Cancer Patients
- African American Women with Breast Cancer Less Likely to Have Newer, Recommended Surgical Procedure
- Diabetes Drug May Also Protect Against Breast Cancer
- Most Women Who Have Double Mastectomy Don’t Need It
- Sleep Efficiency Increases Breast Cancer Survival Rates
- False-Positive Mammograms Lead to Willingness for Future Screening
Patient HIV Free After Stem Cell Transplant
Infection with HIV requires the presence of a CD4 receptor and a chemokine receptor, principally chemokine receptor 5 (CCR5).
Gero Hütter of the Department of Hematology, Oncology, and Transfusion Medicine at the Charité Universitätsmedizin in Berlin realized that by replacing his patient’s immune cells with cells lacking the CCR5 receptor, his patient might be less vulnerable to HIV infection.
The image is an electron micrograph of HIV budding from cultured lymphocyte.
Hütter performed the bone marrow transplant after finding a donor lacking the CCR5 receptor, and twenty months after transplantation and discontinuation of antiretroviral therapy, the patient remains HIV free.
Bone marrow transplantation has periodically been advocated as a path to HIV cure, but past efforts have been uniformly unsuccessful. However, the case does suggest that targeting CCR5 by other methods, molecular inactivators or RNA fragments that downregulate expression, might be a powerful strategy for delaying onset of disease, if not actually achieving cure.
1. Gero Hütter, et al. Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation. N Engl J Med. 2009 Feb 12;360(7):692-8. PMID: 19213682.
2. Abigail Zuger, MD. Stem-Cell Transplantation Enables Long-Term HIV Control. AIDS Clinical Care.
3. Image from Centers for Disease Control and Prevention